What is MitoSynergy?
MitoSynergy focuses on enhancing cellular energy and overall health through its BioCopper1 line of bioavailable copper supplements. The company's products are engineered to address common concerns such as fatigue, discomfort, and cognitive clarity by supplying essential copper for optimal physiological function. MitoSynergy targets a broad demographic, from health-conscious consumers to individuals managing chronic conditions, aiming to elevate quality of life via nutritional support. Their commitment to high manufacturing standards and customer satisfaction underscores their dedication to trust and efficacy in the competitive health supplement industry.
How much funding has MitoSynergy raised?
MitoSynergy has raised a total of $11K across 1 funding round:
Debt
$11K
Debt (2021): $11K with participation from PPP
Key Investors in MitoSynergy
PPP
Public-Private Partnership
What's next for MitoSynergy?
With its recent moderate growth capital, MitoSynergy is poised for a significant scaling phase, characteristic of a Series A/B growth stage. This strategic investment will likely fuel advancements in product development, market penetration, and operational expansion. The company's focus on essential nutrients for cellular energy suggests a trajectory towards becoming a leader in targeted nutritional solutions, potentially exploring new formulations and broader distribution channels to meet growing consumer demand for scientifically-backed wellness products.
See full MitoSynergy company page
